Narayana Hrudayalaya Ltd Stock Analysis

BSE: 539551 | NSE: NH | Hospital & Healthcare Services | Mid Cap

BSE Share Price 29-Nov-2022 18:01
758.20 10.70 (1.43%)

DeciZen - Make an Informed Decision on Narayana Hrudayalay

Overall Rating

1. Quality

2. Valuation

Fair

3. Price Trend

Semi Strong

Narayana Hrudayalay Price Chart

P/E Ratio (CD) :
34.70
Market Cap :
15,276 Cr.
52-wk low :
530.3
52-wk high :
810.2
Bole Toh?

1. Is Narayana Hrudayalaya Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Narayana Hrudayalaya Ltd is a good quality company.

2. Is Narayana Hrudayalaya Ltd undervalued or overvalued?

The key valuation ratios of Narayana Hrudayalaya Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Narayana Hrudayalaya Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Narayana Hrudayalaya Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Narayana Hrudayalay:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Narayana Hrudayalaya Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 3.9%4.7%1.5%4.7%9%6%6.1%9.9%2.7%21.2%-
Value Creation Index -0.7-0.7-0.9-0.7-0.3-0.6-0.6-0.3-0.80.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 8391,0951,3641,6141,8782,2812,8613,1282,5833,7014,075
YoY Gr. Rt. %-30.5%24.5%18.3%16.4%21.4%25.4%9.3%-17.4%43.3%-
Adj EPS 0.81-0.81.54.22.62.85.8-0.51721.8
YoY Gr. Rt. %-19.1%-180%NA182.3%-37.6%8.9%106.7%-108.2%NA-
BVPS (₹) 29.130.938.442.746.75052.855.454.672.788.1
Adj Net Profit 15.718.9-163084.852.957.7119-9.9347446
Cash Flow from Ops. 44.611076.7174219182279443304485-
Debt/CF from Ops. 5.734.71.514.42.91.621.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.9%14.5%9%43.3%
Adj EPS 39.7%32.6%81.9%NA
BVPS 10.79.311.333
Share Price - 20.3% 36.9% 33.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % 33.4-2.43.69.25.35.510.7-0.926.627.1
Op. Profit Mgn % 9.911.29.411.112.39.810.313.97.618.219.3
Net Profit Mgn % 1.82.10.53.24.92.52.13.9-0.19.610.9
Debt to Equity 0.50.60.50.30.20.80.80.60.60.40.3
Working Cap Days 9897908374797870796584
Cash Conv. Cycle 12654-4-3-3-9-14-139

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 27.10%

Net Profit is growing at healthy rate in last 3 years 81.93%

Debt to equity has declined versus last 3 years average to 0.37

Sales growth is good in last 4 quarters at 20.43%

Sales growth has been subdued in last 3 years 8.96%

Latest Financials - Narayana Hrudayalaya Ltd.

Standalone Consolidated
TTM EPS (₹) 11 21.8
TTM Sales (₹ Cr.) 2,695 4,075
BVPS (₹.) 64.6 88.1
Reserves (₹ Cr.) 1,115 1,596
P/BV 11.58 8.59
PE 67.73 34.70
From the Market
52 Week Low / High (₹) 530.25 / 810.15
All Time Low / High (₹) 181.35 / 810.15
Market Cap (₹ Cr.) 15,276
Equity (₹ Cr.) 204.4
Face Value (₹) 10
Industry PE 64.4

Management X-Ray of Narayana Hrudayalay :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Narayana Hrudayalay

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Narayana Hrudayalaya Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Narayana Hrudayalay on 29-Nov-2022 18:01 is : 758.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Nov-2022 18:01 the market cap of Narayana Hrudayalay stood at ₹ 15,276.
The latest PE ratio of Narayana Hrudayalay as of 29-Nov-2022 18:01 is 67.73.
The latest PB ratio of Narayana Hrudayalay as of 29-Nov-2022 18:01 is 11.58
The 52-week high of Narayana Hrudayalay is ₹ 810.1 and the 52-week low is ₹ 530.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Narayana Hrudayalay is ₹ 2,695 ( Cr.) .

About Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited was incorporated on July 19, 2000 under the Companies Act, 1956. The Company, headquartered in Bengaluru is engaged in providing economical healthcare services. The Company was rebranded as ‘Narayana Health’ in 2013. It has a network of multispecialty and superspeciality hospitals spread across multiple locations.

The company was founded by its Promoter Devi Prasad Shetty, who has over 30 years of medical experience, including as a cardiac surgeon. The company is headquartered in Bengaluru, India, and operates a national network of hospitals in India with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in western and central India. The company’s ‘Narayana Health’ brand is strongly associated with its mission to deliver high quality and affordable healthcare services to the broader population by leveraging its economies of scale, skilled doctors, and an efficient business model.

Business area of the company

The company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals.

Products and Services

  • Anaesthesia & Critical Care
  • Blood Bank
  • Bone Marrow Transplant
  • Breast Cancer
  • Cardiac Surgery - Adult
  • Cardiology - Adult
  • Clinical Nutrition & Dietetics
  • Cranio-Maxillo Facial Surgery
  • Dental Sciences
  • Dermatology and Cosmetology
  • Developmental Medicine
  • Diabetology
  • E.N.T
  • Electrophysiology
  • Emergency Medicine
  • Endocrinology
  • Family Medicine
  • Gastroenterology - Medical
  • Gastroenterology - Surgical
  • Gastrointestinal Oncology
  • General Surgery
  • Genetics
  • Geriatrics
  • Gynaecology - Oncology
  • Haemato Oncology
  • Haematology
  • Head & Neck Surgery - Oncology
  • Heart Transplant
  • Infectious Diseases
  • Integrative Oncology
  • Internal Medicine
  • Interventional Radiology
  • Kidney Transplant - Adult
  • Lab
  • Liver Transplant & HPB Surgery
  • Medical Oncology
  • Microbiology
  • Nephrology
  • Neurology
  • Neurosurgery
  • NICU & PICU
  • Nuclear Medicine
  • Obstetrics & Gynaecology
  • Oncology
  • Ophthalmology
  • Ortho - Oncology
  • Orthopaedics
  • Pain & Palliation - Oncology
  • Pathology
  • Physical Medicine and Rehabilitation
  • Physiotherapy & Rehabilitation
  • Plastic Surgery
  • Psychiatry & Clinical Psychology
  • Pulmonology
  • Radiation Oncology
  • Radiology
  • Reproductive Medicine
  • Rheumatology
  • Robotic Surgery
  • Speech And Swallow Rehabilitation
  • Spine Surgery
  • Surgical Oncology
  • Thoracic Surgery
  • Uro - Oncology
  • Urology
  • Vascular Surgery

Awards

2010:

  • Awarded as the Best Single Speciality Hospital - Cardiology at 'India Healthcare Awards 2010'

2011:

  • A proud recipient of the “India Shining Star CSR Award' for the exceptional CSR work in the health sector

2012:

  • FICCI Health Care Excellence Award
  • Frost and Sullivan India Healthcare Excellence Awards

2013:

  • Financial Times Arcelor Mittal Boldness in Business Awards
  • Inc. India Innovative 100 Award

2014:

  • Narayana health was recognised among world’s top 50 ‘BCG Local Dynamos 2014’ for its exceptional operational efforts.
  • Gold Award winner in Customer Service by Asian Hospital Management Awards
  • Winner of ABP News Brand Excellence Award 2014

2015:

  • Identified for its exceptional work in the department of cardiology, NICS has been named the Best Single Specialty Hospital in India, Cardiology in the CNBC TV 18 & ICICI Lombard India Healthcare Award 2015-16
  • Recognized for its technology enabled innovative primary healthcare services to people living in resource deprived locations in India, Narayana Health has been awarded Public Health Champion Award by WHO India under the category of Innovation
  • NH receives the Healthcare Leadership Awards by Stars of the Industry Group in 2 categories; Outstanding Achievement Awards Healthcare - Social Cause, Healthcare & Social Care Support Award

2016:

  • Health Brand of the Year - Healthcare - India Health & Wellness Awards
  • Quality beyond Accreditation for NH Jaipur at the Global Conclave of Association of Health Care Providers India (AHPI)

2017:

  • Narayana Health was recognized as one of the Best Asian Healthcare Brands by the Economic Times, for its immense contributions & unique initiatives to improve the healthcare industry.
  • Best Cardiac Science Institute of the Year
  • Narayana Superspeciality Hospital Howrah was recognized as the Best Superspeciality Hospital of the Year (Oncology) at the International Healthcare Awards 2017 - country's most authoritative Summit & Awards for the healthcare industry.

2018:

  • Narayana Health won the Silver in Reproductive and Sexual Health Category at India Health & Wellness Summit and Awards.
  • Narayana Health listed in Fortune India 500
  • CSR Excellence in Healthcare

Milestones

  • 2000: Commenced operations from NICS in Bengaluru
  • 2008: The company entered into an investment agreement with the investor Selling Shareholders for the purpose of subscription by the investor Selling Shareholders to 75,414 Equity Shares of Rs 10 each of the company (in the aggregate) for a purchase price of Rs 53,040.55 (approximately) per share, including share premium of Rs 53,030.55 (approximately) per share.
  • 2014: Acquired AHDL.
  • 2014: Acquired the Jubilant Kalpataru Hospital, Barasat, West Bengal.
  • 2014: The company entered into a securities subscription agreement with CDC Group and CDC IOL for subscription to its equity shares and OCDs aggregating to around Rs 300 crore.
  • 2015: Obtained JCI accreditation for HCCI's multispecialty hospital in Cayman Islands.
  • 2018: Narayana Health City Launches ‘Senior Citizen’s Privilege Card’
  • 2018: Narayana Superspeciality Hospital empaneled with CGHS & NHPC
  • 2019: Narayana Health Guwahati opens Day care dialysis center.
  • 2019: Narayana Multispeciality Hospital Launches A Comprehensive Weight Loss Clinic : 1st In Mysore
  • 2019-20: SRCC Children’s Hospital, Mumbai completed 1,000 paediatric cardiac surgeries since its inception strengthening facility’s position as a top-notch medical destination for paediatric treatment
  • 2019-20: Foundation stone laid for setting up a comprehensive Radiation Centre at Health City Cayman Islands
  • 2019-20: Company signed a 3-year contract to deploy and manage NH’s Proprietary Data Intelligence Platform - MEDHA for a PanIndia Hospital Group
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now